ArticleJournal of translational medicine2012

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.

George Fountzilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.